Pricing Log in Create free account

Adherex Technologies Inc. (FENC) vs ProKidney Corp. (PROK)

Adherex Technologies Inc. and ProKidney Corp. are both Biotechnology companies. Adherex Technologies Inc. and ProKidney Corp. are of similar size ($329.3M and $322.0M). Adherex Technologies Inc. has the higher net margin (−5.49% vs −10,288.4%) and the lower return on invested capital (−58.9% vs 0.00%). Across the 14 metrics below, Adherex Technologies Inc. leads on 8 and ProKidney Corp. on 6.

Valuation

Metric FENC PROK Biotechnology median
P/E n/m n/m 10.60
P/S 5.77 262.28 9.40
P/B 8.05 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5.38 40.72 9.02
Earnings yield (1.25%) (47.83%) (32.88%)
Free cash flow yield (0.60%) (65.96%) (23.13%)

Profitability

Metric FENC PROK Biotechnology median
Gross margin 93.73% 100.00% 68.51%
Operating margin (1.90%) (21,664.55%) 0.00%
Net margin (5.49%) (10,288.39%) 0.00%
Free cash flow margin (3.44%) (17,300.61%) 0.00%
Return on equity (18.58%) 8.92% (51.96%)
Return on assets (5.39%) (27.10%) (46.06%)
Return on invested capital (58.89%) 0.00% 0.00%

Growth

Metric FENC PROK Biotechnology median
Revenue growth (TTM) 77.83% — 6.76%
EPS growth (last fiscal year) (2,087.50%) 16.13% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FENC PROK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.85 8.36 4.97
Net debt to EBITDA 6.02 1.70 1.01

Dividend

Metric FENC PROK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FENC PROK Biotechnology median
Market cap 329.29m 322.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack